Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers

NCT02217644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 653048 H3PO4 solution
DRUG: BI 653048 H3PO4 low dose capsule
DRUG: BI 653048 H3PO4 high dose capsule
DRUG: Placebo

Sponsor

Boehringer Ingelheim